Endogenous Molecules as Neuroprotective Entities for the Treatment of Ischemic Stroke

内源性分子作为治疗缺血性中风的神经保护实体

• 批准号: 311947
• 负责人: Purcell Mary I
• 金额: $ 1.27万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2013
• 资助国家: 加拿大
• 起止时间: 2013-12-01 至 2014-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=311947&lang=en
• 关键词: Brain Infraction; Chelation; Divalent Metal Cations; Ischemia; Medicinal Chemistry; Molecular Modelling; Neurodegenerative Disease; Spectroscopy; Synthetic Organic Chemistry; Zinc

Stroke is an ever-increasing problem in the aging Canadian population. It is the third leading cause of death, associated with highly prevalent risk factors such as high blood pressure, diabetes, and obesity. Although strokes are typically physically de

中风是加拿大老龄化人口中不断增加的问题。 它是死亡的第三大原因，与高血压，糖尿病和肥胖症等高度普遍的危险因素有关。 尽管中风通常是身体上的